Christoph Röllig

机构：University Hospital Carl Gustav Carus, Klinik und Poliklinik für Psychotherapie und Psychosomatik, Technische Universität Dresden · ORCID：0000-0002-3791-0548

发表论文 528 篇 · 总被引 17637 次 · h-index 60

代表论文

• Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial (2025 · Blood · 被引 6)
• Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia (2025 · npj Precision Oncology · 被引 4)
• In Silico Trial Simulation with Artificial Intelligence-Generated Synthetic Control Cohorts Reproduces Results of a Randomized Controlled Trial in Acute Myeloid Leukemia (2026 · medRxiv · 被引 1)
• Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation (2026 · Blood · 被引 1)
• Generating reliable synthetic clinical trial Data: The role of hyperparameter optimization and domain constraints (2025 · Information Sciences · 被引 1)
• Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia (2026 · Leukemia)